Walleye Capital LLC bought a new stake in shares of Morningstar, Inc. (NASDAQ:MORN – Free Report) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund bought 944 shares of the business services provider’s stock, valued at approximately $301,000.
Several other hedge funds also recently modified their holdings of the stock. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC boosted its position in shares of Morningstar by 7.5% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 88,679 shares of the business services provider’s stock valued at $28,299,000 after buying an additional 6,205 shares during the last quarter. MetLife Investment Management LLC boosted its position in shares of Morningstar by 1.2% during the third quarter. MetLife Investment Management LLC now owns 15,159 shares of the business services provider’s stock valued at $4,838,000 after buying an additional 179 shares during the last quarter. Healthcare of Ontario Pension Plan Trust Fund lifted its holdings in Morningstar by 282.2% during the third quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 22,931 shares of the business services provider’s stock worth $7,318,000 after acquiring an additional 16,931 shares during the period. BNP Paribas Financial Markets lifted its holdings in Morningstar by 16.9% during the third quarter. BNP Paribas Financial Markets now owns 5,983 shares of the business services provider’s stock worth $1,909,000 after acquiring an additional 866 shares during the period. Finally, Quantbot Technologies LP lifted its holdings in Morningstar by 259.3% during the third quarter. Quantbot Technologies LP now owns 13,769 shares of the business services provider’s stock worth $4,394,000 after acquiring an additional 9,937 shares during the period. Hedge funds and other institutional investors own 57.02% of the company’s stock.
Morningstar Stock Up 0.4 %
Shares of NASDAQ:MORN opened at $357.57 on Wednesday. The company has a debt-to-equity ratio of 0.55, a quick ratio of 1.14 and a current ratio of 1.14. The firm has a market capitalization of $15.33 billion, a P/E ratio of 47.24 and a beta of 1.19. The stock has a 50 day moving average price of $341.21 and a 200-day moving average price of $317.98. Morningstar, Inc. has a 52-week low of $269.51 and a 52-week high of $362.01.
Morningstar Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Investors of record on Friday, October 3rd will be paid a $0.455 dividend. The ex-dividend date of this dividend is Friday, October 3rd. This represents a $1.82 annualized dividend and a dividend yield of 0.51%. This is an increase from Morningstar’s previous quarterly dividend of $0.41. Morningstar’s dividend payout ratio is presently 24.04%.
Insider Buying and Selling
In other Morningstar news, Director William M. Lyons sold 750 shares of the stock in a transaction on Wednesday, October 30th. The stock was sold at an average price of $331.88, for a total transaction of $248,910.00. Following the sale, the director now directly owns 12,840 shares in the company, valued at approximately $4,261,339.20. This trade represents a 5.52 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Chairman Joseph D. Mansueto sold 118 shares of the firm’s stock in a transaction on Friday, November 15th. The stock was sold at an average price of $342.13, for a total value of $40,371.34. Following the completion of the transaction, the chairman now owns 10,788,378 shares in the company, valued at approximately $3,691,027,765.14. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 49,188 shares of company stock worth $16,823,772 in the last 90 days. Insiders own 37.70% of the company’s stock.
Analyst Ratings Changes
A number of brokerages recently commented on MORN. UBS Group began coverage on Morningstar in a report on Tuesday, October 8th. They set a “buy” rating and a $390.00 price target on the stock. Redburn Atlantic lowered Morningstar from a “buy” rating to a “neutral” rating and set a $340.00 price target on the stock. in a report on Wednesday, October 9th. BMO Capital Markets reiterated an “outperform” rating and set a $352.00 price target on shares of Morningstar in a report on Wednesday, August 28th. Finally, StockNews.com lowered Morningstar from a “buy” rating to a “hold” rating in a research note on Monday, December 2nd. Two analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $360.67.
Get Our Latest Stock Report on MORN
About Morningstar
Morningstar, Inc provides independent investment insights in the United States, Asia. Australia, Continental Europe, the United Kingdom, and internationally. The company operates in five segments: Morningstar Data and Analytics; PitchBook; Morningstar Wealth; Morningstar Credit; and Morningstar Retirement.
Further Reading
- Five stocks we like better than Morningstar
- What is the Shanghai Stock Exchange Composite Index?
- Survey Reveals: Which States Saw the Biggest Investment Gains in 2024?
- Where to Find Earnings Call Transcripts
- Amazon’s Healthcare Gamble: A New Era of Medical Disruption
- Investing in Commodities: What Are They? How to Invest in Them
- Semiconductor Giant Synopsys Slides 14% — Time to Take Notice
Receive News & Ratings for Morningstar Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Morningstar and related companies with MarketBeat.com's FREE daily email newsletter.